Jump to main content
Jump to site search

Issue 16, 2019
Previous Article Next Article

Biocatalytic retrosynthesis approaches to D-(2,4,5-trifluorophenyl)alanine, key precursor of the antidiabetic sitagliptin

Author affiliations

Abstract

The integration of biocatalytic steps in retrosynthetic analysis of a target molecule offers multiple advantages, such as reduction of the environmental footprint of the process, viability of milder and safer reaction conditions, and accessibility of transformations that are challenging with traditional chemical synthesis. Herein, six chemo-enzymatic routes are described for the synthesis of a fluorinated D-phenylalanine derivative, precursor of the blockbuster antidiabetic drug sitagliptin. All routes start from the same aldehyde precursor and involve at least one biocatalytic step, including reductive amination, transamination, deracemisation, hydroamination, and alkene reduction. The target molecule was obtained in 2–5 steps from the aldehyde, with ee up to >99% and in 36–62% isolated yield. Furthermore, as part of one of the routes, the first example of a fully biocatalytic conversion of a cinnamic acid derivative to the corresponding D-phenylalanine (formal D-selective hydroamination) is reported.

Graphical abstract: Biocatalytic retrosynthesis approaches to d-(2,4,5-trifluorophenyl)alanine, key precursor of the antidiabetic sitagliptin

Back to tab navigation

Supplementary files

Publication details

The article was received on 06 Jun 2019, accepted on 18 Jul 2019 and first published on 18 Jul 2019


Article type: Paper
DOI: 10.1039/C9GC01902B
Green Chem., 2019,21, 4368-4379

  •   Request permissions

    Biocatalytic retrosynthesis approaches to D-(2,4,5-trifluorophenyl)alanine, key precursor of the antidiabetic sitagliptin

    F. Parmeggiani, A. Rué Casamajo, D. Colombo, M. C. Ghezzi, J. L. Galman, R. A. Chica, E. Brenna and N. J. Turner, Green Chem., 2019, 21, 4368
    DOI: 10.1039/C9GC01902B

Search articles by author

Spotlight

Advertisements